AFP and hepatocellular carcinoma: AFP is frequently used for the diagnosis of HCC, including onset and recurrence of HCC after liver transplant.[20] However, approximately 20% of HCC patients with low AFP level are poorly diagnosed.[21] For these patients, the 3-miRNA panel possessed significant superiority compared to AFP alone.